The Connect® Lymphoma Disease Registry is a study that collects information from people with different types of non-Hodgkin lymphoma (NHL), a kind of blood cancer. This study is observational, meaning that it looks at people’s health and treatment over time without giving any new medicines or treatments. It focuses on two types of NHL: diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL), especially when these diseases come back or don't respond to treatment.

The study records the treatments participants receive as per usual care and checks how well these treatments work. It also collects information on how the disease and its treatment affect patients’ quality of life and social support.

• The study does not provide new drugs; it only observes regular treatments.
• Participants must be 18 or older and have been treated for NHL before.
• It's important for participants to be able to provide their health information and complete surveys about their quality of life.

Those interested should not be part of another trial with experimental treatments and should not have other active cancers.